The bioengineering consortium's forty-seven-member interdisciplinary team successfully synthesized twelve novel pharmaceutical compounds, including 3,4-methylenedioxymethamphetamine derivatives, achieving a ninety-three-point-seven percent yield through chromatographic purification techniques at precisely twenty-three degrees Celsius.